NVNO Earnings

Quarterly EPS
$-10.68
Q4 2024
$-7.75
Q1 2025
$-11.52
Q2 2025
$-7.89
Q3 2025
$-6.04
Q4 2025
$-5.89
Q1 2026
$-5.37
Q2 2026
$-6.29
Q3 2026
Latest RevenueN/A
Latest Net Income-4367000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$6.290-4367000—+20.3%
Q2 2026-$5.370-3600000—+53.4%
Q1 2026-$5.890-3849000—+24.0%
Q4 2025-$6.040-3736000—+43.4%
Q3 2025-$7.890-4539000—+35.6%
Q2 2025-$11.520-6694000—-6.2%
Q1 2025-$7.750-4503000—+28.6%
Q4 2024-$10.680-6229000—+16.2%
Q3 2024-$12.250-5642000——
Q2 2024-$10.850-4956000——
Q1 2024-$10.850-4992000——
Q4 2023-$12.750-5649000——
enVVeno Medical (NVNO) — Earnings